FDA WARNING_LETTER - Daniel W. Siegert DBA Siegert Swiss - November 16, 2012

FDA WARNING_LETTER for Daniel W. Siegert DBA Siegert Swiss on November 16, 2012. Product: Drugs. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for Daniel W. Siegert DBA Siegert Swiss on November 16, 2012. Product: Drugs. Access full analysis and detailed observations.

Violation Codes

21 CFR 556.113

21 U.S.C. 360b

21 U.S.C. 342(a)(4)

21 U.S.C. 342(a)(2)(C)(ii)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Daniel W. Siegert DBA Siegert Swiss

Inspection Date

November 16, 2012

Product Type

Drugs

Office

Kansas City District Office

People

ID: c9c493b2-e7dd-4daf-93ab-4e1442289cad

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox